Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Replimune Group Inc (NASDAQ: REPL)

 
REPL Technical Analysis
3
As on 9th Jun 2023 REPL STOCK Price closed @ 22.47 and we RECOMMEND Buy for LONG-TERM with Stoploss of 18.64 & Buy for SHORT-TERM with Stoploss of 21.38 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

REPLSTOCK Price

Open 22.59 Change Price %
High 22.66 1 Day -0.09 -0.40
Low 22.00 1 Week 2.98 15.29
Close 22.47 1 Month 5.08 29.21
Volume 648559 1 Year -3.77 -14.37
52 Week High 29.75 | 52 Week Low 13.32
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
REPL
Daily Charts		 REPL
Intraday Charts		 Whats New @
Bazaartrend		 REPL
Free Analysis
 
REPL Important Levels Intraday
RESISTANCE23.74
RESISTANCE23.33
RESISTANCE23.08
RESISTANCE22.83
SUPPORT22.11
SUPPORT21.86
SUPPORT21.61
SUPPORT21.20
 
REPL Forecast April 2024
Share
4th UP Forecast48.68
3rd UP Forecast40.27
2nd UP Forecast35.08
1st UP Forecast29.88
1st DOWN Forecast15.06
2nd DOWN Forecast9.86
3rd DOWN Forecast4.67
4th DOWN Forecast-3.74
 
REPL Weekly Forecast
4th UP Forecast27.85
3rd UP Forecast26.12
2nd UP Forecast25.06
1st UP Forecast23.99
1st DOWN Forecast20.95
2nd DOWN Forecast19.88
3rd DOWN Forecast18.82
4th DOWN Forecast17.09
 
REPL Forecast2024
4th UP Forecast56.85
3rd UP Forecast45.82
2nd UP Forecast39.01
1st UP Forecast32.19
1st DOWN Forecast12.75
2nd DOWN Forecast5.93
3rd DOWN Forecast-0.88
4th DOWN Forecast-11.91
 
 
REPL Other Details
Segment EQ
Market Capital 1400830464.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
REPL Address
REPL
 
REPL Latest News
 
Your Comments and Response on Replimune Group Inc
 
REPL Business Profile
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts. Address: 500 Unicorn Park Drive, Woburn, MA, United States, 01801
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service